Literature DB >> 15254442

Human papillomavirus infection and disease in HIV-infected individuals.

Michael E Hagensee1, Jennifer E Cameron, Janet E Leigh, Rebecca A Clark.   

Abstract

The possibility of increases in both oral and anogenital pathologic conditions due to human papillomavirus (HPV) in patients infected with the human immunodeficiency virus (HIV) is of concern and is the focus of numerous current research studies. HIV-infected women are at higher risk for cervical HPV detection, for infection with high-oncogenic-risk types of HPV, for persistent HPV infection, for cervical cytologic abnormalities, and for cervical intraepithelial neoplasms. HIV-infected men are at increased risk for anal HPV infection, for anal infection with high oncogenic-risk types of HPV, for persistent anal HPV infection, and for anal intraepithelial defects. Recent studies have shown an increased risk of oral warts in HIV-infected individuals despite treatment with highly active antiretroviral therapy (HAART). Oral HPV infection rates have not declined since the initiation of HAART, and evidence suggests that the rates may have actually increased in white HIV-infected males.

Entities:  

Mesh:

Year:  2004        PMID: 15254442     DOI: 10.1097/00000441-200407000-00008

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  32 in total

1.  Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations.

Authors:  Michael S McLemore; Missak Haigentz; Richard V Smith; Gerard J Nuovo; Llucia Alos; Antonio Cardesa; Margaret Brandwein-Gensler
Journal:  Head Neck Pathol       Date:  2010-03-24

Review 2.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

Review 3.  [Human papilloma virus-induced disease in HIV-positive patients].

Authors:  R Wienecke; N H Brockmeyer; A Kreuter
Journal:  Hautarzt       Date:  2006-11       Impact factor: 0.751

4.  Sociodemographic Predictors of Anal Cancer Screening and Follow-up in Human Immunodeficiency Virus-Infected Individuals.

Authors:  Jessica S Wells; Marcia M Holstad; Deborah Watkins Bruner
Journal:  Cancer Nurs       Date:  2018 Sep/Oct       Impact factor: 2.592

5.  Determinants of newly detected human papillomavirus infection in HIV-infected and HIV-uninfected injection drug using women.

Authors:  Darcy F Phelan; Stephen J Gange; Linda Ahdieh-Grant; Shruti H Mehta; Gregory D Kirk; Keerti Shah; Patti Gravitt
Journal:  Sex Transm Dis       Date:  2009-03       Impact factor: 2.830

6.  Individual and partner risk factors associated with abnormal cervical cytology among women in HIV-discordant relationships.

Authors:  Jason Soh; Anne F Rositch; Laura Koutsky; Brandon L Guthrie; Robert Y Choi; Rose K Bosire; Ann Gatuguta; Jennifer S Smith; James Kiarie; Barbara Lohman-Payne; Carey Farquhar
Journal:  Int J STD AIDS       Date:  2013-09-18       Impact factor: 1.359

7.  Comparison of the immunogenicity of Cervarix® and Gardasil® human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults.

Authors:  Lars Toft; Martin Tolstrup; Martin Müller; Peter Sehr; Jesper Bonde; Merete Storgaard; Lars Østergaard; Ole S Søgaard
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

8.  Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men.

Authors:  Jasmeet Chadha Singh; Victoria Kuohung; Joel M Palefsky
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12-01       Impact factor: 3.731

Review 9.  Factors influencing familial decision-making regarding human papillomavirus vaccination.

Authors:  Heather L Gamble; James L Klosky; Gilbert R Parra; Mary E Randolph
Journal:  J Pediatr Psychol       Date:  2009-12-04

10.  Rapid progression of an anal Buschke-Lowenstein tumour into a metastasising squamous cell carcinoma in an HIV-infected patient.

Authors:  A Handisurya; A Rieger; Z Bago-Horvath; C Schellenbacher; A Bankier; A Salat; G Stingl; R Kirnbauer
Journal:  Sex Transm Infect       Date:  2009-08       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.